Qiao Li, Ph.D. is a Research Associate Professor in the Section of General Surgery in the Surgery Department. Dr. Li received his bachelor's degree from Wuhan University in Wuhan, China and a master's degree from the Chinese Academy of Sciences. He received his Ph.D. in Immunology and Biological Sciences from Wayne State University in Detroit, Michigan. Dr. Li completed his postgraduate training in Molecular Biology and Cell Biology from the Brigham and Women's Hospital and Dana-Farber Cancer Institute at Harvard Medical School in Boston, Massachusetts. He was an Assistant Professor of Biology at Wuhan University from 1985 through 1989. Dr. Li joined the faculty at the University of Michigan in 1997.
Tumor-reactive T cells for the adoptive immunotherapy of cancer
Prof. Yang obtained his PhD from University of Toronto, Canada and received postdoctoral training in the Scripps Research Institute in USA. He is currently the Head of Department of Biomedical Sciences, and Yeung Kin-Man Chair Professor of Biomedical Sciences in City University of Hong Kong. The research interest of Yang’s group focuses development of biochip technology and nanotechnology for molecular diagnostics and therapeutic applications. Prof. Yang has published over 280 peer-reviewed scientific papers and received 23 USA/China patents. He has delivered more than 80 invited lectures in international conferences and universities, and trained 28 PhD and MPhil graduates and numerous postdoctoral fellows in his laboratory. He holds honorary professorships in Zhejiang University, the Third Military Medical University, and the PLA Graduate School of Medicine, China. Prof. Yang is a member of the Grant Review Boards of Hong Kong Healthcare and Medical Research Fund and Innovation and Technology Fund. He also served as the Technical Advisor for the Nanotechnology and Advanced Material Institute (NAMI) of Hong Kong. He has been awarded the Chunhui Scholar Award by the Ministry of Education in China in 2003, the K. C. Wong Foundation Award in 2004, the Shenzhen Science and Technology Innovation Award in 2006, the Hong Kong Technological Achievement Grand Award in 2007, the Natural Science Award by the Ministry of Education in 2015, and the Wuxi AppTech Life Science and Chemistry Award in 2016.
Dr Jenny Wang is a Senior Lecturer and ARC Future Fellow at the Faculty of Medicine, UNSW Australia and a Group Leader of Cancer and Stem Cell Biology at Children's Cancer Institute. She received her PhD in Molecular Biology and Biochemistry from Macquarie University, and undertook postdoctoral training with A/Prof Scott Armstrong in cancer stem cell biology at Harvard Medical School/Harvard Stem Cell Institute in Boston USA (2005–2011).